The levels of tumor biomarkers CEA, CA125 and CA199 were elevated in CRC patients compared with in non-CRC subjects (P < 0.05), while the AFP and CA153 has no significant difference between these two kinds of patients (P > 0.05). This evidence concerns the gene CEACAM5 and neoplasm.